Verastem Inc.

NASDAQ: VSTM · Real-Time Price · USD
7.53
-0.20 (-2.59%)
At close: Aug 15, 2025, 11:15 AM
-2.59%
Bid 5.54
Market Cap 463.44M
Revenue (ttm) 24K
Net Income (ttm) -148.88M
EPS (ttm) -3.5
PE Ratio (ttm) -2.15
Forward PE -2.98
Analyst Buy
Ask 9.63
Volume 621,560
Avg. Volume (20D) 2,640,061
Open 7.52
Previous Close 7.73
Day's Range 7.52 - 7.76
52-Week Range 2.24 - 9.10
Beta 0.83

About VSTM

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VSTM
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for VSTM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Verastem has released their quartely earnings on Aug 7, 2025:
  • Revenue of $2.14M misses estimates by $4.8M, with -78.63% YoY decline.
  • EPS of -0.63 exceeds estimates by 0.05, with -3.28% YoY decline.
  • Next Earnings Release

    Verastem Inc. is scheduled to release its earnings on Nov 5, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    6 days ago
    +19.93%
    Verastem shares are trading higher after the compa... Unlock content with Pro Subscription
    2 months ago
    -19.95%
    Verastem shares are trading lower. The company provided updated data for the dose escalation part of its Phase 1/2 trial of GFH375.